166 related articles for article (PubMed ID: 26788177)
1. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging: A novel approach to assessing treatment in locally advanced esophageal cancer patients.
Gu L; Xie X; Guo Z; Shen W; Qian P; Jiang N; Fan Y
Niger J Clin Pract; 2021 Dec; 24(12):1800-1807. PubMed ID: 34889788
[TBL] [Abstract][Full Text] [Related]
4. The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Liu P; Li X; Chen Z; Long X; Pang Q; Deng S; Gu J
Cancer Manag Res; 2021; 13():6065-6078. PubMed ID: 34377025
[TBL] [Abstract][Full Text] [Related]
5. Correlation of K
Wang D; Liu S; Fu J; Zhang P; Zheng S; Qiu B; Liu H; Ye Y; Guo J; Zhou Y; Jiang H; Yin S; He H; Xie C; Liu H
J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38910009
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Xu L; Ge X; Sun N; Liu X
Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
[TBL] [Abstract][Full Text] [Related]
7. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
9. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging.
Zhai J; Zheng W; Zhang Q; Wu J; Zhang X
Oncol Lett; 2019 May; 17(5):4237-4244. PubMed ID: 30944618
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary study of semi-quantitative and quantitative dynamic contrast-enhanced MRI in evaluating the response to concurrent chemoradiotherapy in patients with non-small cell lung cancer].
Xiuli T; Han O; Ning W; Li L; Feng Y; Ying S; Peihua W; Lü L
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):272-7. PubMed ID: 26462891
[TBL] [Abstract][Full Text] [Related]
13. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
[TBL] [Abstract][Full Text] [Related]
14. The Assessment of Prostate Cancer Aggressiveness Using a Combination of Quantitative Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Zhu G; Luo J; Ouyang Z; Cheng Z; Deng Y; Guan Y; Du G; Zhao F
Cancer Manag Res; 2021; 13():5287-5295. PubMed ID: 34239327
[TBL] [Abstract][Full Text] [Related]
15. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
[No Abstract] [Full Text] [Related]
16. Quantitative Multiparametric MRI May Augment the Response to Radiotherapy in Mid-Treatment Assessment of Patients with Esophageal Carcinoma.
Xie T; Ye Z; Pang P; Shao G
Oncol Res Treat; 2019; 42(6):326-333. PubMed ID: 31064001
[TBL] [Abstract][Full Text] [Related]
17. [Diagnose pituitary adenoma using dynamic enhanced MRI: a quantitative approach].
Zheng W; Zhai J; Chen Y
Zhonghua Yi Xue Za Zhi; 2015 Jun; 95(23):1837-41. PubMed ID: 26712402
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]